https://www.news-medical.net/news/20221103/Study-explores-the-potential-use-of-anti-thymic-stromal-lymphopoietin-monoclonal-antibody-as-an-adjuvant-in-allergic-immunotherapy.aspx
A new study investigated the impact of a monoclonal anti-thymic stromal lymphopoietin (TSLP) antibody on subcutaneous allergen immunotherapy (SCIT) efficacy among patients with allergic rhinitis.
Create an account or login to join the discussion